![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Bardsley-Elliot A. Noble S.
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.12, Iss.4, 1999-10, pp. : 325-333
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Sandrini Giorgio Perrotta Armando Tassorelli Cristina Nappi Giuseppe
Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Grujich Nick N Gawel Marek J
Expert Opinion on Investigational Drugs, Vol. 10, Iss. 10, 2001-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Färkkilä Markus Kallela Mikko
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Spotlight on Eletriptan in Migraine
By McCormack Paul L. Keating Gillian M.
CNS Drugs, Vol. 20, Iss. 11, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Eletriptan: A Viewpoint by Timothy J. Steiner
By Steiner T.J.
CNS Drugs, Vol. 12, Iss. 4, 1999-10 ,pp. :